Crizanlizumab

ATC B06AX01 · 5 markets · 5 records

Crizanlizumab 5 markets · 5 records Forms

US 1 records · 1 strengths

GB 1 records · 1 strengths

  • 100 mg/10 mLinjectionAdakveo 100mg/10ml concentrate for solution for infusion vials

AU 1 records · 1 strengths

  • 100 mginjectionADAKVEO crizanlizumab 10 mg/mL concentrate for solution for infusion vial unknown
The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.